Leaflet PAMIDRONATE HOSPIRA 3mg / ml concentrate for solution for infusion

Product code:
W68901001
Quantity:
1
Indicated for:
bone metastases; tumor-induced hypercalcemia
Route of administration:
infusion
Substance:
pamidronic acid (bisphosphonate)
ATC
M05BA03 — Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates

Precautions:

Take on an empty stomach

Take on an empty stomach

Take this medicine on an empty stomach.

Avoid milk, calcium, iron, or antacids

Avoid milk, calcium, iron, or antacids

Do not take with milk, calcium, iron, magnesium, or antacids if separation is recommended.

Pamidronic acid is a bisphosphonate used to treat hypercalcemia associated with cancer and to prevent skeletal complications in patients with bone metastases. It works by inhibiting osteoclast-mediated bone resorption, thereby reducing bone loss.

It is administered intravenously and is effective in lowering high calcium levels in the blood, which can occur in certain types of cancer. It is also used to reduce the risk of bone fractures and other complications in patients with bone metastases.

Common side effects include fever, flu-like symptoms, and bone or muscle pain. In rare cases, it may cause osteonecrosis of the jaw, especially in patients who have recently undergone dental procedures.

Patients receiving pamidronic acid treatment should be monitored for kidney function, as the drug can affect the kidneys, particularly at high doses.

General data about PAMIDRONATE HOSPIRA 3mg / ml

Substance:
pamidronic acid
Date of latest medicines list:
01-06-2026
Product code:
W68901001
Concentration:
3mg / ml
Pharmaceutical form:
concentrate for solution for infusion
Quantity:
1
Product type:
Original
Price:
247.11 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PFIZER HOLDING FRANCE - FRANTA
Holder:
PFIZER ROMANIA S.R.L. - ROMANIA
Number:
717/2022/01
Shelf life:
3 years

Concentrations available for pamidronic acid

  • 15mg
  • 15mg/ml
  • 30mg
  • 3mg/ml
  • 60mg
  • 6mg/ml
  • 9mg/ml

Compensation lists for PAMIDRONATE HOSPIRA 3mg / ml Pfizer

NHP 3 (C2) - NHP oncology

Price
247.11 RON
Copayment
247.11 RON
Patient
0.00 RON

NHP 6.6 (C2) - Imperfect osteogenesis

Price
247.11 RON
Copayment
247.11 RON
Patient
0.00 RON